Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 19 (RPL21P19)
- Target
- RPL21P19
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L21 pseudogene 19 (RPL21P19) is classified as a processed pseudogene in the human genome and does not encode a functional protein. It is related by sequence to the functional gene ribosomal protein L21 (RPL21), which is a structural component of the 60S ribosomal subunit important for protein synthesis[4][6]. Being a pseudogene, RPL21P19 does not possess known biological functions, disease associations, or direct therapeutic relevance; rather, it represents a non-coding genomic element derived from duplication or reverse transcription of the ancestral RPL21 gene[4][6]. There are no known drugs, mechanisms of action, or clinical biomarkers related to this pseudogene. Pseudogenes like RPL21P19 are commonly found in the genome, often listed among related functional genes and other pseudogenes in gene databases[4][6]. RPL21P19 is not considered a therapeutic target or a functional protein, and it plays no established biological or disease-related roles.
- Other names
- RPL21_7_151RPL21P19
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 19 (RPL21P19).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 19 (RPL21P19).